Protection against lipopolysaccharide-induced death by fluoroquinolones.
about
Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.Immunomodulating activity of quinolones: review.Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.Potent Antiedematous and Protective Effects of Ciprofloxacin in Pulmonary Ricinosis.Anthracyclines induce DNA damage response-mediated protection against severe sepsis.Lack of interaction of fluoroquinolones with lipopolysaccharides.Inhibition of secretion of interleukin-1alpha and tumor necrosis factor alpha by the ketolide antibiotic telithromycin.Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages.Comparative therapeutic effect of steroidal and non-steroidal anti-inflammatory drugs on pro-inflammatory cytokine production in water buffalo calves (Bubalus bubalis) naturally infected with bronchopneumonia: a randomized clinical trial.Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.Influence of Escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits.Effect of antibiotics on polymorphonuclear neutrophil apoptosis.Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis.Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
P2860
Q31140106-0EB2C94D-E195-4158-ABC2-C849B1B65BD1Q33575993-6CD802D3-705D-412E-B121-98845DA5BB19Q33983140-18E9F4FE-C8A4-4E24-8A6A-1DBD1552DB9FQ34368520-A40AEDD8-2FE2-4994-B5DF-4C155A191F91Q34487226-89FCB6D6-E229-42F9-A86D-7BB30077D600Q34562603-A6C61577-4138-4D1B-8604-6B21F1450F92Q36669130-1560171C-40B2-4E55-BE4F-B8C7F3D194DCQ37428623-EB1D8884-D068-4C56-82E3-59CDDB47C054Q38549117-5265A9D8-D4AE-46C4-B854-EF7FE927D943Q39651564-C60ED350-2B1A-4CAD-923F-8507C76513CFQ39658071-4D51000D-CAC7-4CB6-9E12-2F2282EA3D41Q39730644-D44C1AE9-2227-40F4-8AEB-769E0379A44CQ40083424-789C78DE-1DF1-4EBD-B12F-6BDC6F80BB6EQ40874282-B01C2913-AF93-4E09-B7D0-3C039238688CQ43839550-4DF52510-AE6D-4BCD-93C2-1344222C14DAQ43995315-6271E3C6-D24D-4498-BB19-D3103012AF0AQ44151739-F6DD8E6C-5E48-45CE-B302-487E70C6F63EQ44569280-488FE993-78C0-4593-BC21-4B59348619AEQ54435973-2EBAFD80-5A1E-42A4-BD48-99E8D99EC661
P2860
Protection against lipopolysaccharide-induced death by fluoroquinolones.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Protection against lipopolysaccharide-induced death by fluoroquinolones.
@ast
Protection against lipopolysaccharide-induced death by fluoroquinolones.
@en
type
label
Protection against lipopolysaccharide-induced death by fluoroquinolones.
@ast
Protection against lipopolysaccharide-induced death by fluoroquinolones.
@en
prefLabel
Protection against lipopolysaccharide-induced death by fluoroquinolones.
@ast
Protection against lipopolysaccharide-induced death by fluoroquinolones.
@en
P2093
P2860
P1476
Protection against lipopolysaccharide-induced death by fluoroquinolones.
@en
P2093
F G Araujo
J S Remington
T R Slifer
P2860
P304
P356
10.1128/AAC.44.11.3169-3173.2000
P407
P577
2000-11-01T00:00:00Z